EWTX Sale Disclosure
Derakhshan Behrad · SEC Form 4 · Filed Aug 14, 2026
Sale
Calculated transaction value
$95.08K
Derakhshan Behrad Chief Business Officer
EWTX
Transaction date
Aug 12, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 2 days later
EWTX daily price context
Close on/before transaction
$43.56
Aug 12, 2026
Close before public filing
$43.18
Aug 13, 2026
Return since public filing
+2.87%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,171 shares @ $43.79
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001853109-26-000001
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$223.42K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX Current | Sale | Aug 12, 2026 | $95.08K |
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $13.53K |
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $6.67K |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Award | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $108.15K |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Award | Aug 12, 2026 | $0 |